Results
Anthem Biosciences Reports Strong FY26 Results with 15% Revenue Growth
Anthem Biosciences reported 15.2% revenue growth to ₹21,243 million and 31.1% PAT growth to ₹5,918 million in FY26, demonstrating strong financial performance.
The company successfully completed its ₹
